Promotional material

Alobar holoprosencephaly: description in brief

This leaflet can help healthcare professionals speak with people, following suspected or confirmed diagnosis of alobar holoprosencephaly (HPE).

• From: Public Health England
• Published: 1 July 2009
• Last updated: 27 April 2020 — See all updates

This publication was withdrawn on 27 April 2020

This has been withdrawn as alobar holoprosencephaly is not a condition screened for by the fetal anomaly screening programme.

More information is available at: Fetal anomalies: screening, conditions, diagnosis, treatment.

Documents

Alobar holoprosencephaly (HPE) information for parents

PDF, 693 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This publication explains the fetal anomaly alobar holoprosencephaly.

The document includes information about:

• what the condition is
• how common it is
• how it is diagnosed and confirmed
• what treatment is available
• what the outlook for the baby is
• what happens next
• how likely it is to happen in future pregnancy
• where more support and information is available

Published 1 July 2009

Last updated 27 April 2020 + show all updates

1. 27 April 2020

   Publication withdrawn as Alobar holoprosencephaly is not a condition screened for by the fetal anomaly screening programme.

2. 1 July 2009

   First published.